Drug Manufacturers - General · Conshohocken, Pennsylvania, United States
$0.42
-1.43% (-$0.01)2026-07-09
Smart-Money SignalNeutral · 53/100— Insider open-market flow is flat over 90 days
Net Income-$9.0M
EPS$-0.31
Market Cap$16.8M
Price Performance
Historical data including institutional events
Company Profile
R
Raza Bokhari
CEO & Executive Director
Medicus Pharma Ltd., a biotech/life sciences company, focuses on developing clinical development programs of therapeutic assets in the United States.
It is developing SKNJCT-003, which is in Phase 2 study for the treatment of basal cell carcinoma of the skin.
Medicus Pharma Ltd. has a strategic collaboration with the Gorlin Syndrome Alliance to access to SKINJECT in Patients with Gorlin Syndrome.
The company was formerly known as Interactive Capital Partners Corporation and changed its name to Medicus Pharma Ltd. in September 2023.
The company was incorporated in 2008 and is headquartered in Conshohocken, Pennsylvania.
